Riskpilot← Back to searchSign inGet full accessBCG Medical AB
ABDissolvedOrg 5564668324Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19930 employees
Revenue 2021
SEK 83K
+2667% vs 2020
EBITDA margin
1.2%
+105% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK 1K
+105% vs 2020
| Revenue | SEK 83K | +2667% |
| EBITDA | SEK 1K | +105% |
| Net profit | SEK 1K | +105% |
| Total assets | SEK 101K | -49% |
| Equity | SEK 101K | -49% |
| Employees | 0 | — |
Legal name
BCG Medical AB
Org number
5564668324
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7 maj 1993
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Bolaget skall bedriva verksamhet inom hälsa och sjukvård. Bolaget ska sälja och marknadsföra agenturprodukter till den skandinaviska sjukvården. Bolaget skall även bedriva tjänster inom äldreomsorg såsom hemtjänst, hushållsnära tjänster och annan förenlig verksamhet samt utföra och marknadsföra metoder och produkter inom äldreomsorg.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 635 | 1 405 | 763 | 3 | 83 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 186 | 106 | 2 | −20 | 1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 186 | 106 | 2 | −20 | 1 |
| Net financials | — | — | — | — | — |
| Profit before tax | 186 | 107 | 1 | −20 | 1 |
| Tax | −30 | −25 | −0 | −0 | −0 |
| Net profit | 156 | 82 | 1 | −20 | 1 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 377 | 448 | 240 | 200 | 101 |
| Equity | 283 | 205 | 206 | 200 | 101 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 94 | 243 | 34 | 0 | 0 |
| Total debt | 94 | 243 | 34 | — | — |
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
20172021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172021
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20172021
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20172021
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
GG Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 – 2022 |
LG Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BCG Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnar Göran Helge Engdahl | Deputy Chief Executive Officer | 0 companies |
| Leif Göran Sparrman | Chief Executive Officer | 0 companies |
| Helén Karin Hilland | Chairman | 0 companies |
| Helen Karin Sparrman | Board of Directors | 0 companies |